Cargando…
GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis
Background: Fuzheng Kang’ai decoction (FZKA) has been widely used to treat Non-Small Cell Lung Cancer (NSCLC) patients in China for decades, showing definitively curative effects in clinic. Recently, we found that FZKA could induce NSCLC cell ferroptosis, another type of programmed cell death (PCD),...
Autores principales: | Zhao, Yue-Yang, Yang, Yu-Qi, Sheng, Hong-Hao, Tang, Qing, Han, Ling, Wang, Su-Mei, Wu, Wan-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043103/ https://www.ncbi.nlm.nih.gov/pubmed/35496303 http://dx.doi.org/10.3389/fphar.2022.851680 |
Ejemplares similares
-
Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial
por: Yang, Xiao-Bing, et al.
Publicado: (2015) -
The Effect of Transarterial Chemoembolization in Combination With Kang’ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study
por: Wan, Yue-Meng, et al.
Publicado: (2017) -
Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway
por: Wang, Sumei, et al.
Publicado: (2020) -
Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2017) -
Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2021)